GBP2 and lobular neoplasia: Subsequently, by establishing an LN mouse model, we confirmed that QS can significantly ameliorate renal pathological damage in LN, and its therapeutic mechanism may be related to affecting purine metabolism and regulating the GBP2/NF-kappaB axis (Figure 11).